Sale!

MPZ Gene CMT2I Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MPZ Gene CMT2I Genetic Test is a specialized diagnostic procedure designed to detect mutations in the MPZ gene, which are associated with Charcot-Marie-Tooth disease type 2I (CMT2I). Charcot-Marie-Tooth disease is a group of hereditary disorders that affect the peripheral nerves, leading to muscle weakness and sensory loss, primarily in the arms and legs. The MPZ gene encodes for myelin protein zero, a critical component of the myelin sheath that insulates nerve fibers. Mutations in this gene can disrupt nerve function and lead to the symptoms observed in CMT2I.

This genetic test is crucial for individuals who exhibit symptoms of peripheral neuropathy, have a family history of Charcot-Marie-Tooth disease, or for whom there is a clinical suspicion of CMT2I. Early and accurate diagnosis through the MPZ Gene CMT2I Genetic Test can guide treatment options, inform prognosis, and assist with family planning decisions.

The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. DNA Labs UAE utilizes state-of-the-art technology to ensure accurate and reliable test results. The cost of the MPZ Gene CMT2I Genetic Test is 4400 AED. This investment can provide individuals and families with crucial information about their genetic health, enabling them to make informed medical and lifestyle decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MPZ Gene CMT2I Genetic Test

At DNA Labs UAE, we offer the MPZ Gene CMT2I Genetic Test to help diagnose and manage Charcot-Marie-Tooth disease type 2I (CMT2I). This rare genetic disorder affects the peripheral nerves and can cause muscle weakness and atrophy.

Test Details

The MPZ gene is associated with CMT2I. Our next-generation sequencing (NGS) technology allows us to identify mutations in the MPZ gene that cause this disorder. This test can confirm a clinical diagnosis, identify carriers of the disease, and provide information for genetic counseling.

Components

  • Test Name: MPZ Gene CMT2I Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to the MPZ Gene CMT2I Genetic Test, it is important to provide the clinical history of the patient. This includes any relevant information about the symptoms and medical background. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with MPZ Gene CMT2I.

NGS Technology

NGS testing is a highly accurate and efficient method for identifying genetic mutations. It is increasingly available in clinical settings and allows for comprehensive analysis of the MPZ gene.

Conclusion

If you suspect that you or a loved one may have CMT2I, our MPZ Gene CMT2I Genetic Test can provide valuable insights. Contact our genetics department to schedule an appointment with a neurologist and get started on the path to diagnosis and management.

Test Name MPZ Gene CMT2I Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MPZ Gene CMT2I NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MPZ Gene CMT2I
Test Details

The MPZ gene is associated with Charcot-Marie-Tooth disease type 2I (CMT2I), a rare genetic disorder that affects the peripheral nerves and causes muscle weakness and atrophy. A next-generation sequencing (NGS) genetic test can identify mutations in the MPZ gene that cause CMT2I. This test can be used to confirm a clinical diagnosis, identify carriers of the disease, and provide information for genetic counseling. NGS testing is a highly accurate and efficient method for identifying genetic mutations and is becoming increasingly available in clinical settings.